Professor Amos Toren
Pediatric hematologist-oncologist. Head of the Department of Pediatric Hemato-Oncology and Bone Marrow Transplantation at the children's hospital. Former head of the Department of Hematology and Transfusion Medicine at the Sackler Faculty of Medicine, Tel Aviv University.
Professor Amos Toren is an outstanding pediatric hematologist and oncologist whose achievements and authority are recognized far beyond Israel. Besides his clinical work, he earned a master's degree in Health Systems Management from the Leon Recanati School. The professor is an honorary member of the cord blood storage committee established by the Ministry of Health. His professional interests are conservative and surgical treatment of hematological malignancies in children and adolescents, therapy of solid tumors in patients under 30, and management of relapses in patients with recurrent and secondary malignant blood diseases.
Amos Toren conducts active research on innovative cell therapy techniques (T-CARs and CAR-T) for CD19-resistant cancers, the induction of cytotoxic T lymphocytes in advanced pediatric cancers, and gentle destruction of brain tumors in children.
The professor is a recognized expert in allogeneic and autologous bone marrow transplantation at an early age. His experience and achievements in this clinical field are recognized internationally.
In 1990 Amos Toren graduated with honors from the Faculty of Medicine of Tel Aviv University. He did an internship in clinical genetics, then a residency in the hematology department of the children's hospital. In 1993 he improved his qualifications in oncology, and in 1995 in pediatric hemato-oncology. Alongside his main positions he studied health management at the Leon Recanati Business School. He headed the Department of Hematology at the Faculty of Medicine of Tel Aviv University for two terms. In 2008 he was awarded the academic title of professor of medical sciences.
Professor Amos Toren is an honorary member of the following professional societies:
- Israeli Society of Hematology
- Israeli Pediatric Association
- European Group for Blood and Marrow Transplantation
- European Society for Pediatric Hematology
- American Society of Hematology
- Children's Oncology Group
- Center for International Blood and Marrow Transplant Research
- Cord blood storage committee, Israel Ministry of Health
Currently Amos Toren heads the Department of Hemato-Oncology.
Amos Toren's priority is the comprehensive treatment of hematological malignancies and lymphoproliferative disorders in children and adolescents.
The professor's expertise includes:
- Differential diagnosis of tumors of the hematopoietic and lymphatic systems
- Treatment of relapsed hematological malignancies and those resistant to traditional therapy, using experimental methods
- Genetic diagnostics and counseling
- CAR-T and T-CARs cell therapy under individual protocols
- Immunotherapy with monoclonal antibodies
- Targeted biotherapy
- Poly- and monochemotherapy with new-generation cytotoxic and cytostatic agents
- Allogeneic and autologous bone marrow transplantation
Progressive treatment methods and a balanced approach allow Amos Toren and his team to achieve positive results in most cases.